DeDora Capital’s Usana Health Sciences USNA Stock Holding History

DeDora Capital’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-64	Closed	-$5K	–	373
2022 Q1	$5K	Buy	+64	New	+$5.77K	﹤0.01%	348

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

DeDora Capital's USNA Position: Q2 2022 in Review

DeDora Capital sold out of Usana Health Sciences (USNA) in Q2 2022, closing a stake of 64 shares — an estimated $5K sold.

DeDora Capital first reported a position in USNA in Q1 2022 and held it in 1 quarter. The position peaked at $5K in Q1 2022. 182 funds tracked by Wall St. Rank hold USNA as of Q2 2022.

DeDora Capital reported no remaining Usana Health Sciences position as of Q2 2022 after selling out during the quarter.
DeDora Capital sold 64 Usana Health Sciences shares in Q2 2022, an estimated $5K.
DeDora Capital first reported a position in Usana Health Sciences in Q1 2022 and held it in 1 quarter.
DeDora Capital's Usana Health Sciences position peaked at $5K in Q1 2022.
182 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2022.

Based on DeDora Capital's 13F filing for Q2 2022, filed 27 Jul 2022.